Advertisement

Topics

Jubilant Life's net profit drops by 12.6% to Rs. 125 cr in Q2

07:34 EDT 1 Nov 2017 | PharmaBiz
Related Biotechnology, Pharmaceutical and Healthcare News

Jubilant Life Sciences, a Rs. 5,750 crore plus pharma major, has reported lower consolidated net profit of Rs. 125 crore during the second quarter ended September 2017 as compared to Rs. 144 crore in the similar quarter

Original Article: Jubilant Life's net profit drops by 12.6% to Rs. 125 cr in Q2

NEXT ARTICLE

More From BioPortfolio on "Jubilant Life's net profit drops by 12.6% to Rs. 125 cr in Q2"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
 

News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches


BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2017 BioPortfolio Limited. Site developed by Alacrify Ltd.